The sunitinib malate market for pancreatic cancer is projected to reach USD 76.7 Million by 2021, at a CAGR of 13.9% from 2016 to 2021.
Tag:- Sunitinib malate market
MarketsandMarkets™ - Apr 21, 2021
Sunitinib Malate Market worth $ 76.7 Million by 2021
MarketsandMarkets™ - Apr 20, 2019
Sunitinib Malate Market worth $ 76.7 Million by 2021
MarketsandMarkets™ - Mar 16, 2019
Sunitinib Malate Market worth $ 76.7 Million by 2021
MarketsandMarkets™ - Jan 25, 2019
Sunitinib Malate Market worth $ 76.7 Million by 2021
MarketsandMarkets™ - Dec 20, 2018
Sunitinib Malate Market worth $ 76.7 Million by 2021
MarketsandMarkets™ - Nov 17, 2018
Sunitinib Malate Market Worth 76.7 Million USD by 2021
MarketsandMarkets™ - Jul 07, 2018
Sunitinib Malate Market worth 76.7 Million USD by 2021
MarketsandMarkets™ - Apr 23, 2017